Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Maze Therapeutics, Inc. (MAZE) had Weighted-Average Shares Outstanding (Basic) of 43.80M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-33.68M |
|
-- |
|
-- |
|
$36.47M |
|
$-36.47M |
|
$2.79M |
|
$-33.68M |
|
$-33.68M |
|
$-33.68M |
|
$-33.68M |
|
$-33.68M |
|
$-33.68M |
|
$-36.47M |
|
$-35.83M |
|
|
Weighted-Average Shares Outstanding (Basic) |
43.80M |
43.80M |
|
$-0.77 |
|
$-0.77 |
|
| Balance Sheet Financials | |
$271.15M |
|
$6.01M |
|
$32.37M |
|
$303.52M |
|
$19.90M |
|
-- |
|
$21.38M |
|
$41.28M |
|
$262.24M |
|
$262.24M |
|
$262.24M |
|
43.85M |
|
| Cash Flow Statement Financials | |
$-59.57M |
|
$-0.69M |
|
$127.99M |
|
$197.90M |
|
$265.63M |
|
$67.73M |
|
$6.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-60.26M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.84% |
|
-12.84% |
|
-11.10% |
|
-12.84% |
|
$5.98 |
|
$-1.38 |
|
$-1.36 |
|